| Ms Kellie M Barker, MA CF-SLP | |
|
3802 Turkeyfoot Rd, Erlanger, KY 41018-2838 | |
| (859) 342-0200 | |
| Not Available |
| Full Name | Ms Kellie M Barker |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 3802 Turkeyfoot Rd, Erlanger, Kentucky |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1669083762 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 265369 (Kentucky) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Ms Kellie M Barker, MA CF-SLP 3426 Ridgewood Dr, Erlanger, KY 41018-2820 Ph: (859) 609-6990 | Ms Kellie M Barker, MA CF-SLP 3802 Turkeyfoot Rd, Erlanger, KY 41018-2838 Ph: (859) 342-0200 |
News Archive
A new pilot study by investigators at Memorial Sloan-Kettering Cancer Center (MSKCC) found that breast cancer patients can be treated safely with a "dose-dense" regimen of standard chemotherapy agents and the antibody trastuzumab (Herceptin®), a drug that has previously been shown to cause cardiac toxicity.
The scientific world was astonished when, in 2011, Chinese researchers claimed to have found evidence suggesting that minute fragments of plant genetic material - so-called microRNA molecules - of rice ingested from food could play a role in regulating physiological processes in the human body. If this is indeed true, it might even be possible to deliberately modify human physiological functions via this route, for instance by incorporating microRNAs into novel functional foods.
Starpharma Holdings Ltd (ASX:SPL; OTCQX: SPHRY) is pleased to report that recruitment is now 100% complete for its Phase 2 clinical trial to investigate the ability of VivaGel® to prevent the recurrence of BV, and also for the first of two pivotal Phase 3 studies of VivaGel® for the treatment of BV.
Biologists at Heidelberg University have discovered new approaches for the treatment of cancer. They investigated how a special signalling molecule, the epidermal growth factor (EGF), stimulates the separation of chromosomes in the cell. The researchers were able to demonstrate that EGF accelerates the division of the cell nucleus, i.e. mitosis, as well as boosts precision in chromosome segregation.
On the skin's surface, bacteria are abundant, diverse and constant, but inflammation is undesirable. Research at the University of California, San Diego School of Medicine now shows that the normal bacteria living on the skin surface trigger a pathway that prevents excessive inflammation after injury.
› Verified 2 days ago
Creative Therapy Solutions Pllc Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 441 Division St, Erlanger, KY 41018 Phone: 859-342-6387 Fax: 859-342-4284 | |
Peyton Dean, MS CCC-CLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2990 Riggs Rd, Erlanger, KY 41018 Phone: 859-727-9330 | |
Ms. Hannah Leslie Kauffman, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2990 Riggs Rd, Erlanger, KY 41018 Phone: 859-727-9330 | |
Lauren Lawler, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2990 Riggs Rd # 41018, Erlanger, KY 41018 Phone: 859-727-9330 | |
Paige Gieske, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2990 Riggs Rd, Erlanger, KY 41018 Phone: 859-727-6700 |